Muscle Cell News Volume 11.18 | Oct 19 2026

    0
    18








    2026-10-19 | MUSCN 11.18


    Muscle Cell News by STEMCELL Technologies
    Vol. 11.18 – 19 October, 2026
    TOP STORY

    A Muscle-Enriched Mitochondrial Protein Regulates Postnatal Heart Growth through Mitonuclear Ubiquinone-PPAR Signaling

    By integrating mitochondrial proteome annotations with mouse and human transcriptomic datasets, scientists identified Coenzyme Q10a, a striated muscle-enriched mitochondrial protein, as a regulator of postnatal cardiac growth.
    [Proceedings of the National Academy of Sciences of the United States of America]

    Full Article
    Request your free EasySepâ„¢ sample and get a pair of highly coveted science socks.
    PUBLICATIONSListed by the impact factor of the journal

    Cardiomyocyte-Enriched OTUD5 Alleviates Pathological Myocardial Hypertrophy by Deubiquitinating STAT3 and Modulating the STAT3-PGC-1α Axis

    Researchers investigated the role and molecular mechanisms of OTUD5, a member of the deubiquitinase family, in pathological cardiac hypertrophy. OTUD5 expression is greatly increased in cardiomyocytes from hypertrophic hearts.
    [Experimental & Molecular Medicine]

    Full Article | Graphical Abstract

    Structural and Functional Remodeling of Large-Scale Cardiac Tubes

    Investigators engineered large tubular constructs from hiPSC-derived cardiomyocytes and human foreskin fibroblasts via a rotating mold technology in four independent experiments.
    [Biofabrication]

    Full Article

    Low-Dose Juglone Attenuates Pressure Overload-Induced Cardiac Hypertrophy through Lys207-Dependent FoxO1 Activation and Mitochondrial Protection

    Scientists investigated the efficacy, safety window, and redox-regulatory mechanism of juglone, a naturally occurring 5-hydroxy-1,4-naphthoquinone.
    [Pharmacological Research]

    Full Article | Graphical Abstract

    Restoration of Cyclin A2 by Glabridin Reverses Pathological Cell Cycle Arrest and Drives Cardiac Repair in HFpEF

    The authors identified aberrant cardiomyocyte cell cycle arrest as a previously unrecognized pathological driver of heart failure with preserved ejection fraction (HFpEF) that hinders tissue repair.
    [Acta Pharmacologica Sinica]

    Abstract | Graphical Abstract

    The SGLT2 Inhibitor Empagliflozin Directly Binds Cardiac JNK3, Uncouples c-Jun/c-Fos Signaling, and Confers Cardioprotection in Diabetic Cardiomyopathy

    Researchers aimed to identify a direct cardiac target of empagliflozin and define the downstream signaling mechanisms mediating its cardioprotective effects in diabetic cardiomyopathy.
    [Diabetes & Metabolism Journal]

    Abstract | Full Article

    Systems Analysis Reveals Neuregulin-1 Control of Cardiomyocyte Size and Shape Mediated by Distinct PI3K and p38 Pathways

    Investigators combined high-content morphological profiling, phospho-protein arrays, and systems modeling to characterize the diverse forms of hypertrophy induced by angiotensin II, endothelin-1, insulin growth factor-1, and neuregulin-1.
    [Journal of Molecular and Cellular Cardiology]

    Abstract | Graphical Abstract

    Circadian Disruption Exacerbates Alcohol-Induced Cardiac Injury through Impaired Cellular Quality Control and Increased Cardiomyocyte Death

    Scientists performed RNA-sequencing and transcriptomic analysis on hearts from C57BL/6 J mice exposed to alcohol for ten weeks, and collected at two distinct circadian time points.
    [Molecular and Cellular Biochemistry]

    Abstract

    Exercise Improves Heart Failure by Regulating Cardiomyocyte Autophagy via the ILF3/lncRNA NEAT1 Axis

    Researchers aimed to investigate whether exercise can influence heart failure progression by regulating expression of the lncRNA NEAT1, and to elucidate its molecular mechanisms.
    [Molecular and Cellular Biochemistry]

    Abstract

    An Integrative Transcriptomic Atlas of ALS and Aging Skeletal Muscle Defines Shared and Distinct Molecular Programs of Degeneration

    Researchers used the SOD1G93A amyotrophic lateral sclerosis (ALS) mouse model and wild-type mice across the lifespan to generate an integrated single-nucleus transcriptomic atlas of skeletal muscle, mapping changes associated with ALS and aging.
    [Proceedings of the National Academy of Sciences of the United States of America]

    Abstract

    Titin Extension Explains Residual Force Enhancement in Skeletal Muscle

    To test whether titin may be responsible for residual force enhancement, investigators used multiple titin immunolabels on single isolated myofibrils to approximately track the migration of individual titin segments in real-time.
    [Proceedings of the National Academy of Sciences of the United States of America]

    Abstract

    Effect of Serum on Smooth Muscle Cell Phenotype in 3D Tissue-Engineered Microvessels

    Researchers reported a 3D microfluidic-based tissue-engineered model with human brain smooth muscle cells (SMCs) forming a microvessel within a collagen I hydrogel. Using this platform, they demonstrated that serum-free culture conditions are essential to prevent SMC overproliferation.
    [ACS Biomaterials Science & Engineering]

    Abstract | Graphical Abstract
    Join us in our mission to advance the pursuit of scientific knowledge by supplying high-quality, innovative reagents, tools and services that enable life science research.
    REVIEWS

    Are Both Hemolysis and Impaired Myocyte Integrity Associated with Glucose-6-Phosphate Dehydrogenase Deficiency?

    In this review of current case reports of glucose-6-phosphate dehydrogenase deficiency, the authors explore whether the myocyte also undergoes a similar oxidative stress as a red blood cell.
    [Seminars in Perinatology]

    Abstract
    INDUSTRY AND POLICY NEWS

    Cytokinetics Announces Health Canada Approval of MYQORZO® (Aficamten) for the Treatment of Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy

    Cytokinetics, Incorporated announced that Health Canada has issued a Notice of Compliance authorizing MYQORZO® (aficamten) for the treatment of symptomatic obstructive hypertrophic cardiomyopathy of New York Heart Association class II-III in adult patients.
    [Cytokinetics, Incorporated]

    Press Release

    Epicrispr Biotechnologies Awarded $8 Million CIRM Grant to Advance EPI-321 for FSHD

    Epicrispr Biotechnologies announced that it has been awarded an $8 million grant from the California Institute for Regenerative Medicine (CIRM) to support the ongoing first-in-human clinical trial of EPI-321, the company’s epigenetic therapy for facioscapulohumeral muscular dystrophy (FSHD).
    [Epicrispr Biotechnologies (BusinessWire)]

    Press Release
    FEATURED EVENT

    Cell Press Symposia: Biological Function in 3D: Structure, Dynamics, and AI

    November 5-7, 2026
    Shenzhen, China

    > See All Events

    JOB OPPORTUNITIES

    Assistant, Associate or Full Professor – Nuclear Medicine and Theranostics, Radiological Sciences, Oncology

    University of California Los Angeles – Los Angeles, California, United States

    Proteomics Specialist – Structural Proteomics

    Human Technopole – Milan, Italy

    Assistant or Associate Professor – Cell Biology

    University of Virginia – Charlottesville, Virginia, United States

    Instructor – Molecular & Human Genetics

    Baylor College of Medicine – Houston, Texas, United States

    Postdoctoral Research Associate – Cardiometabolic Disease

    University of Nebraska-Lincoln – Lincoln, Nebraska, United States

    > See All Jobs

    Submit (1)
    Brought to you by
    stemcell-logo-for newsletter-2


    1618 Station Street

    Vancouver, BC, V6A 1B6, Canada

    Unsubscribe or manage your subscriptions.

    View the Science News privacy policy here.